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Abstract
Background: Medication errors (MEs) are among the most common types of medical errors and one of the most
common and preventable causes of iatrogenic injuries. The aims of the present study were; (i) to determine the
incidence and types of medication prescribing errors (MPEs), and (ii) to identify some potential risk factors in a
pediatric inpatient tertiary care setting in Saudi Arabia.
Findings: A five-week retrospective cohort study identified medication errors in the general pediatric ward and
pediatric intensive care unit (PICU) at King Abdulaziz Medical City (KAMC) through the physical inspection of
physician medication orders and reviews of patients’ files. Out of the 2,380 orders examined, the overall error rate
was 56 per 100 medication orders (95% CI: 54.2%, 57.8%). Dose errors were the most prevalent (22.1%). These were
followed by route errors (12.0%), errors in clarity (11.4%) and frequency errors (5.4%). Other types of errors were
incompatibility (1.9%), incorrect drug selection (1.7%) and duplicate therapy (1%). The majority of orders (81.8%)
had one or more abbreviations. Error rates were highest in prescriptions for electrolytes (17.17%), antibiotics
(13.72%) and bronchodilators (12.97%). Medication prescription errors occurred more frequently in males (64.5%),
infants (44.5%) and for medications with an intravenous route of administration (50.2%). Approximately one third of
the errors occurred in the PICU (33.9%).
Conclusions: The incidence of MPEs was significantly high. Large-scale prospective studies are recommended to
determine the extent and outcome of medication errors in pediatric hospitals in Saudi Arabia.
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Introduction
Medication errors (MEs) are one of the most common
types of medical errors and one of the most common
and preventable causes of iatrogenic injuries [1]. MEs
contribute to the morbidity and mortality of hospitalized
patients. In the USA, MEs have been found to be
responsible for 7,000 patient injuries per year, with a
similar incidence and consequences in the UK [2,3].
Approximately one third of adverse drug events (ADEs)
are associated with medication errors and are thus pre-
ventable [4]. MEs occur in 6.5 of 100 adult hospital
admissions and 5 of 100 adult medication orders [5].
When medication errors occur, pediatric patients have
a much higher risk of death than adults [6]. There are
many factors that put children at a greater risk for
medication errors, such as their variations in age and
weight, high intra-patient variability, rapid changes in
the pharmacokinetic properties of drugs in children, and
the frequent use of “off-label” indications in children
[1,7-9]. Reports of MEs in children are becoming more
common, yet the findings of many of the reports are
conflicting [10]. In a systematic review, Miller et al. [11]
found that 5 to 27% of inpatient orders contained errors.
Creating a prescription is an early step in medication
use; therefore, reviewing orders and prescriptions by
pharmacists and nurses is critical for detecting errors
and preventing adverse impacts on patients [12]. In
pediatrics, the prescribing and ordering phases, followed
by the administration phase, are associated with the
most errors (usually dosing errors) [1,3,11]. Prescription
errors occur at a rate of 3 to 20% of all prescriptions in
hospitalized pediatric patients and 10.1% of children
seen in emergency departments [8,13]. In the Gulf
region, few studies have explored the significance of
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of these studies has targeted pediatric inpatients. The
electronic prescription system implemented by govern-
ment health care facilities in Dubai has helped reduce
medication errors by 50% [15]. The aims of the present
study were to identify, in a pediatric inpatient tertiary
care setting in Saudi Arabia, (i) the incidence and types
of medication prescribing errors (MPEs) and (ii) some
potential risk factors for MPEs.
Materials and methods
Study Setting
This study was conducted in the general pediatric wards
and the pediatric intensive care unit (PICU) of King
Abdulaziz Medical City (KAMC), which is a tertiary
care hospital in Riyadh, the capital of Saudi Arabia. The
pediatric/neonatal care units at KAMC are composed of
general pediatric wards; medical, surgical and cardiac
intensive care units; and oncology and pediatric emer-
gency units. The total capacity of these wards is
approximately 280 beds, which represents approximately
30% of the overall hospital capacity.
Study design
This was a retrospective cohort study of physician medi-
cation orders over a period of five weeks in King Abdu-
laziz Medical City, Riyadh, Saudi Arabia.
Study population
This study included all of the medication orders that
were prescribed in the general pediatric wards -for chil-
dren up to 14 years of age - and the pediatric intensive
care unit (PICU) during the designated study period.
The following orders were not included in the study:
orders from the pediatric cardiac wards, the pediatric
oncology wards, or the neonatal intensive care unit
(NICU); orders corrected by the pharmacist prior to the
review; errors in medication reorders; doses of antipyre-
tics that were no more than 30% above the maximum
dose; and verbal orders.
Measurement
T h em e d i c a t i o no r d e r sw e r ew r i t t e nb yt h ep e d i a t r i c
medical staff of residents, fellows and consultants. They
used either standard blank physician order sheets, a
number of special order sheets (e.g., an antibiotics order
sheet or an immunoglobulin order sheet), or pre-printed
order-dependent protocols and clinical pathways. Copies
of these original orders were sent to the pharmacy via
fax or carried by the nurses or pharmacy aides. All of
the medication orders were reviewed by staff pharma-
cists and entered into a computerized pharmacy data
system prior to dispensation. The information on each
medication order, including the date of birth, the
diagnosis upon admission, any reported medication
allergies, body weight, and a complete medication profile
for the present hospitalization, was reviewed by the
pharmacist. Two clinical pharmacists covered all of the
orders for the pediatric patients.
Data were collected daily, and the following were
examined: (1) the types of errors in terms of the drug
selection, dose, frequency, route, order clarity, incompat-
ibility, and therapy duplication; (2) the drug route of
administration; (3) the hospital location; (4) the patient’s
age; and (5) the patient’s gender. The use of unapproved
abbreviations was recorded. All of the medication pre-
scribing errors were then classified into two main cate-
gories: (i) potentially harmful errors (including all
potential ADEs) and (ii) non-harmful errors (e.g., miss-
ing information, missing weight, illegibility, abbreviation
errors, and trailing zeros) [8]. The pediatric staff was
not informed of the study during the data collection
period to assure the validity of the results.
Operational definitions
A prescription error was defined as an incorrect or inap-
propriate drug selection (based on indications, contrain-
dications and other factors), dose, route, rate of
administration, or frequency. A prescription error also
included illegible handwriting, an incomplete order
(missing the dose, route, or frequency), incompatibility,
incorrect instructions for using the drug product, and
the use of non-standard nomenclature or abbreviations
that requires further interpretation [4,11,12,16,17].
Because the definition of a medication error is non-uni-
form across different studies, the literature was thor-
oughly reviewed, and the categories were allocated
accordingly.
Ethical issues
This study was approved by the research committee at
King Abdullah International Medical Research Center,
King Saud Bin-Abdulaziz University for Health Sciences,
Riyadh, Saudi Arabia.
Results
Types and incidence of medication errors
In the study period, a total of 2,380 medication orders
were analyzed. In these, 1,333 medication errors were
found, representing 56% (95% CI: 54.2, 57.8), as shown
in table 1. The majority of these errors were classified as
potentially harmful (1,051, 78.8%). Regarding the type of
error, the incidence of dose errors was the highest
(22.1%), followed by route errors (12.0%), order clarity
(11.4%) and dose frequency (5.4%). Other types of errors
were incompatibility (1.9%), incorrect drug selection
(1.7%) and duplicate therapy (1%). Miscellaneous errors
(0.4%) included drug-drug interactions, drug-food
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monitoring.
Dose errors constituted more than one third of the
errors (39.4%), with overdose as the main type of dose
error (47.3%). A missed route was the main type of
route error (94.8%), while a missed frequency was the
main type of frequency error (73.6%). Medication pre-
scription errors occurred the most frequently in males
(64.5%), infants (44.5%) and intravenous routes of
administration (50.2%). Approximately one third of the
errors occurred in the PICU (33.9%) (table 2).
Errors and medication category
Figure 1 shows that the largest number of errors were
associated with prescribing electrolytes (17.2%), followed
by antibiotics (13.7%), bronchodilators (12.9%), narcotic
analgesics (11.6%), gastrointestinal medications (6.9%),
non-narcotic analgesics (5.7%), cardiac medications
(5.3%), sedatives and hypnotics (5%), steroids (4.8%),
topical medications (4.5%) and vitamins (1.7%).
Figure 2 shows that the majority of incompatibility errors
(97%) occurred in prescribing electrolytes, while drug selec-
tion errors were committed mainly in prescribing narcotic
analgesics (37%). Dose errors were committed in prescrib-
ing antibiotics (18%), electrolytes (16%), bronchodilators
and narcotic analgesics (13% each). Route errors were
represented in the prescription of bronchodilators (30%),
electrolytes (18%), cardiac medications (14%) and steroids
(8%). Frequency errors were committed in prescribing anti-
biotics (18%), narcotic analgesics (16%), gastrointestinal
medications (12.6%), and bronchodilators (12%). Duplicate
therapy errors were committed mainly in prescribing seda-
tives and hypnotics (42%) and antibiotics (23%).
Using the list of dangerous abbreviations of the Joint
Commission, the study found that these abbreviations
were highly prevalent (81.8%). They were in the form of
QD (11.4%), a trailing zero after decimal point (e.g., 1.0
mg; 4.9%), a naked decimal point (e.g.,.5 mg; 2.6%), U
(2.5%), and IU (1.9%). Incorrect drug abbreviations were
observed in 17.1% of all of the prescriptions.
Discussion
Medication errors, which are common when prescribing
medication [18], are a serious and potentially harmful
Table 1 Frequency (%) and incidence of medication
prescription errors according to type of error at King
Abdulaziz Medical City, Riyadh, Saudi Arabia
Types of error No. of
errors
% Incidence (95%
CI)
(A). Potentially harmful
errors:
22.1 (9.0, 25.2)
Dose
Overdose 249 47.3
Missed dose 186 35.4
Underdose 79 15.0
Undecided dose 12 2.3
Subtotal * 526 39.4
Route 12.0 (8.5, 15.5)
Missed route 271 94.8
Undecided route 11 3.8
Inappropriate route 4 1.4
Subtotal * 286 21.4
Frequency 5.4 (1.6, 9.2)
Missed frequency 95 73.6
High frequency 17 13.2
Low frequency 11 8.5
Undecided frequency 6 4.7
Subtotal * 129 9.7
Incompatibility 45 3.4 1.9 (-2.1, 5.9)
Wrong drug selection 41 3.1 1.7 (-2.2, 5.6)
Duplicate therapy 24 1.8 1.00 (-3.1, 4.1)
(B) Non-harmful errors:
Clarity 272 20.4 11.4 (7.8, 15.0)
Miscellaneous 10 0.8 0.4 (-5.8, 6.6)
TOTAL 1333 100.0 56.0 (54.2,57.8)
￿ Percentages were calculated from the total number of errors (N = 1,333).
Table 2 Frequency (%) of medication prescription errors
according to potential risk factors at King Abdulaziz
Medical City, Riyadh, Saudi Arabia
Characteristics No. of errors %
Gender
Male 860 64.5
Female 473 35.5
Total 1333 100
Age group
Less than 1 year 593 44.5
1-3 years 249 18.7
4-6 years 167 12.5
7-9 years 43 3.2
10-12 years 281 21.1
Total 1333 100
Administration route
Intravenous 669 50.2
Oral 342 25.7
Inhalation 222 16.6
Topical 60 4.5
Subcutaneous 24 1.8
Intramuscular 16 1.2
Total 1333 100
Location
PICU 452 33.9
Pediatric wards 881 66.1
Total 1333 100
PICU: pediatric intensive care unit.
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Figure 1 Incidence (%) of medication errors in the different medication categories.
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Duplicate therapy(0.8%)
Incompatibility(3.4%)
Drug selection(3.1%)
Frequency(9.7%)
Clarity(20.4%)
Wrong route(21.4%)
Wrong dose(39.4%)
Electrolyte Antibiotic Bronchodilator Narcotic analgesic Gastrointestinal
Non narcotic analgestic Cardiac Steroid Sedative and hypnotic
Figure 2 Types of medication errors by medication category.
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lyzed in the present study, 1,333 errors (56%) were iden-
tified. The majority of these errors were classified as
potentially harmful (1,051, 7 8 . 8 % ) .T h i sf i g u r ei sm u c h
higher than the figures of 4.9 and 4.5 errors per 1,000
medication orders reported by Foli [19] for two large
pediatric hospitals in the US and the figures of 5.9 per
1,000 reported by Lesar [20], 5.7% reported by Kaushal
et al. [4], and 5.7% reported by Fortescue et al. [18].
Two more recent studies of medication errors in pedia-
tric intensive care units by Potts [8] and Cimino [21]
found that 3.4 and 11.1% of orders had at least one pre-
scription error. However, the definition of medication
error was non-uniform across these studies [10]. Both
Potts [8] and Fortescue et al. [10] appeared to use a
broader definition of medication error, as errors in both
studies included all types of omissions, such as omis-
sions in the patient’s weight or prescriber’s name [11].
These definitions differ from the definition of an omis-
sion in the present study, which only included a missing
dose, route or frequency.
In general, dosing errors are the most common type
of medication error in children, with overdoses generally
outnumbering under-doses [4,10,20]. In this study, dos-
ing errors were the most common type of error, fol-
lowed by incorrect route, order clarity, and frequency.
Medication errors are more common in sicker patients
with urgent and complex medical conditions [3,22]. In a
previous study, although the total error rate per 100
orders was similar across different settings, serious
errors were much more common in intensive care
environments [23]. In the present study, approximately
one third of the errors occurred in the PICU. This fig-
u r ew a sh i g h e rt h a nt h ef i g u r er e p o r t e db yC i m i n o
(11.1%) [21], and comparable to the figure (33.1%)
reported by Potts [8]. When such a patient needs urgent
care, there is often insufficient time to verify the correct
dosage [24].
According to Foli [19], pediatric patients (2 years old or
less) and pediatric ICU patients received the greatest pro-
portion of errant orders. In the present study, 44.5% of all
errors were in infants less than one year old. Children (<
5 years old) were at the highest risk of errors, and the
risk for infants (< 1 year old) was more than double that
of the next risk-prone group (aged 65 to 70)[19].
The use of abbreviations in prescribing medication has
recently received much attention and has become an
international concern as one of the major causes of
medication errors [16,25,26]. In the present study,
abbreviations were used in 82% of all orders. Abbrevia-
tions were in the form of QD (11.4%), a trailing zero
after the decimal point (.9%), and a naked decimal point
(2.6%). Incorrect abbreviations were found in 17% of all
prescriptions. These figures were compared to those of
Potts [8], who also found drug abbreviation errors
(6.04%) and the use of a trailing zero after the decimal
point (0.81%).
The administration route ranked second as a medica-
tion error in the present study, representing 21.4% of all
errors. This finding was similar to that of a previous
study [4] in which the administration route represented
18% of all errors. The intravenous route was most com-
monly associated with medication errors. This finding
might explain the highest prevalence of errors in pre-
scribing electrolytes and the finding that PICU errors
were more common.
Limitations
The present study has some limitations. First, the study
was only conducted in one setting that does not repre-
sent other health care settings in Saudi Arabia. Thus,
the findings cannot be generalized. Second, the study
period was short (5 weeks), and most of the orders were
collected during the day shift. It was difficult to collect
the orders during the evening and night shifts, during
which more serious mistake sm a yo c c u r .T h i r d ,t h e r e
was no follow-up studying the consequences of these
errors (i.e., deaths and/or adverse events). Fourth, the
incidence of errors was estimated based on the number
of errors and not the number of orders with one or
more errors, which might overestimate the incidence of
errors in this study, making the comparison with other
studies difficult.
Aside from these limitations, we can conclude the
following:
1. The incidence of medication prescription errors in
this tertiary care setting was significantly high. Dosing
errors were the most common type of error, followed by
the wrong route, order clarity, and the wrong frequency.
Approximately one third of the errors occurred in the
PICU, and one half occurred in infants less than one
year old.
2. Pediatricians should help hospitals develop effective
programs to safely provide medications, report medica-
tion errors, eliminate barriers to reporting medication
errors, encourage a non-punitive reporting culture and
create an environment of medication safety for all hospi-
talized pediatric patients.
3. The development, implementation, and assessment
of a computerized physician order entry system, clinical
decision-support systems, ward-based clinical pharma-
cists, and improved communication among physicians,
nurses, and pharmacists are recommended.
4. Large-scale prospective studies are recommended to
determine the extent and outcomes of medication errors
in pediatric hospitals in Saudi Arabia.
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